{
    "title": "Novo Nordisk invests $6 bln in Wegovy production, still far below demand -CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12733511/Novo-Nordisk-invest-6-bln-Denmark-expansions.html",
    "date": "2023-11-10",
    "keywords": [
        "novo",
        "capacity",
        "market",
        "production",
        "company",
        "drug",
        "nordisk",
        "denmark",
        "wegovy",
        "obesity",
        "banker",
        "jacob",
        "gronholtpedersen",
        "friday",
        "weightloss",
        "demand",
        "world",
        "competition",
        "treatment",
        "api",
        "investment",
        "announcement",
        "maggie",
        "fick",
        "londoncopenhagen",
        "maker",
        "executive",
        "industry",
        "success",
        "antiobesity",
        "number",
        "health",
        "organization",
        "epidemic",
        "building",
        "interview",
        "week",
        "astrazeneca",
        "pill",
        "eccogene",
        "decade",
        "approval",
        "growth",
        "kalundborg",
        "site",
        "supply",
        "chain",
        "packaging",
        "glp1",
        "semaglutide",
        "companys",
        "ozempic",
        "portion",
        "capital",
        "expenditure",
        "plan",
        "year",
        "healthcare",
        "constraint",
        "challenge",
        "ability",
        "jorgensen",
        "injection",
        "process",
        "fillfinish",
        "term",
        "contract",
        "sector",
        "spokesperson",
        "construction",
        "capitalisation",
        "gmt",
        "drop",
        "wider",
        "stock",
        "copenhagen",
        "terje",
        "solsvik",
        "editing",
        "lehto",
        "anna",
        "gibbs",
        "tomasz",
        "janowski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}